Kurosh Rahimi

No ORCID on file · 6 papers in corpus
other 2025
Dissecting "Cotyledonoid" Leiomyoma Involved by Adenomyosis
International journal of surgical pathology ·doi:10.1177/10668969241308200
2024
Author response for "Dissecting “Cotyledonoid” Leiomyoma Involved by Adenomyosis"
·doi:10.1177/10668969241308200/v3/response1
2024
Author response for "Dissecting “Cotyledonoid” Leiomyoma Involved by Adenomyosis"
·doi:10.1177/10668969241308200/v2/response1
observational 2019
A COEUR cohort study of SATB2 expression and its prognostic value in ovarian endometrioid carcinoma
The journal of pathology. Clinical research ·doi:10.1002/cjp2.131

The aim of this study was to describe the expression of special AT-rich sequence-binding protein 2 (SATB2) in ovarian endometrioid carcinoma (EC). SATB2 is a nuclear matrix-associated transcription factor that is associated with abnormal ex…

other 2019
The molecular origin and taxonomy of mucinous ovarian carcinoma
Nature communications ·doi:10.1038/s41467-019-11862-x

Mucinous ovarian carcinoma (MOC) is a unique subtype of ovarian cancer with an uncertain etiology, including whether it genuinely arises at the ovary or is metastatic disease from other organs. In addition, the molecular drivers of invasive…

other 2015
The ARID1A pathway in ovarian clear cell and endometrioid carcinoma, contiguous endometriosis, and benign endometriosis
International Journal of Gynecology & Obstetrics ·doi:10.1016/j.ijgo.2015.02.021

OBJECTIVE: To assess ARID1A-encoded protein (BAF250a) and phosphorylated AKT (pAKT) expression, apoptosis, and the DNA damage response pathway in endometrioid and clear cell ovarian cancers (endometriosis-associated ovarian cancers [EAOCs])…